Antiviral Drugs Market Growth by 2035

The antiviral drugs market is estimated to be worth $57 billion in 2022 and is expected to grow at a compounded annual growth rate (CAGR) of 6.3% during the forecast period.

Read More: https://www.rootsanalysis.com/....reports/antiviral-dr

Infectious diseases are known to be one of the top 10 leading causes of deaths, worldwide. In-fact, more than 40 million people are affected by various types of infectious diseases annually. An article published in The Lancet journal reported that COVID-19 alone caused death of over 18 million people in 2020. Further, it has been reported that human immunodeficiency virus (HIV) is anticipated to be the cause for 6.5 million deaths globally, by 2030.

Peptide Synthesis Service Market Revenue, SWOT, PEST Analysis, Growth Factors, 2035

The peptide synthesis service market is estimated to be worth $1.7 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 13.6% during the forecast period.

Read More: https://www.rootsanalysis.com/....reports/peptide-ther

Over the years, the popularity of biologics has led to an evident shift in the focus of pharmaceutical companies, from traditional interventions towards more complex and advanced pharmacological interventions, such as peptide therapeutics. Since the discovery of insulin, the peptide therapeutics market has evolved significantly. Presently, over 80 peptide-based drugs are available in the market for the treatment of an array of diseases, including cancer, chronic pain, diabetes, HIV infection, multiple sclerosis and osteoporosis. Further, since 2017, more than 10 peptide-based drugs have been approved by the USFDA. Of these, LupkynisTM and Zegalogue® were recently approved in 2021, while ImcivreeTM, Victoza®, LUPRON DEPOT®, Zoladex®, Sandostatin® and Somatuline® received approval in 2020.

Blockchain Integration in Healthcare: Market Developments and Outlook

The global blockchain in healthcare market size is estimated to be worth USD 58 million in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 22%, during the forecast period.

Raed More: https://www.rootsanalysis.com/....reports/blockchain-t

The conventional healthcare industry was plagued with various challenges, including fragmented medical records, lack of data integrity, interoperability issues, supply chain management inefficiencies and security breach of patient’s sensitive medical information.

Genome Editing Market Forecast: A Comprehensive Overview

The global genome editing market size for technologies is estimated to be worth USD 3.5 billion in 2023 and is expected to grow at CAGR of 12.6% during the forecast period (2023-2035).

Read More: https://www.rootsanalysis.com/....reports/genome-editi

Genome editing or gene editing is a genetic engineering technique that enables the modification (insertion, deletion or replacement) of a single gene or a set of genes within the genome of an organism. Over the years, the need for genome editing at the desired site in the genome has resulted in the exploration of various genome editing tools that are being developed by gene editing companies; these include zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and CRISPR technology.

Digital Manufacturing: Market Challenges and Future Prospects

Read More: https://www.rootsanalysis.com/....reports/digital-biom

The global digital manufacturing market for biologics is anticipated to grow at a compounded annual growth rate (CAGR) of 18% during the forecast period, driven mainly by the increased focus on industry 4.0 technologies. Digital transformation has also garnered the interest of pharmaceutical industry. It involves incorporating digital technologies across all functions / operations. Digital technologies have been impacting drug discovery to clinical development as well as manufacturing, amongst other functions.